Clinical Trial Update: Allogeneic Multipotent Stromal Cell Treatment for Acute Kidney Injury Following Cardiac Surgery [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating allogeneic multipotent stromal cells for acute kidney injury after cardiac surgery has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Tubular Necrosis

Drugs mentioned

• Allogeneic multipotent stromal cells

Snippet

Sponsor: AlloCure Inc. | Conditions: Kidney Tubular Necrosis, Acute | Phase 1 | Status: COMPLETED